<?xml version="1.0" encoding="UTF-8"?>
<ref id="CIT0008">
 <label>8</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name name-style="western">
    <surname>Farag</surname>
    <given-names>AK</given-names>
   </name>, 
   <name name-style="western">
    <surname>Elkamhawy</surname>
    <given-names>A</given-names>
   </name>, 
   <name name-style="western">
    <surname>Londhe</surname>
    <given-names>AM</given-names>
   </name>, 
   <etal>et al.</etal>
  </person-group>
  <article-title>Novel LCK/FMS inhibitors based on phenoxypyrimidine scaffold as potential treatment for inflammatory disorders</article-title>. 
  <source>Eur J Med Chem</source>
  <year>2017</year>;
  <volume>141</volume>:
  <fpage>657</fpage>–
  <lpage>75</lpage>.
  <pub-id pub-id-type="pmid">29107425</pub-id>
 </mixed-citation>
</ref>
